Home / Business and Economy / Pharma Index Surges, Outpacing Broader Market
Pharma Index Surges, Outpacing Broader Market
6 Jan
Summary
- Nifty Pharma index closed up 1.69% today.
- Divis Laboratories, Ipca Laboratories, and Lupin showed significant gains.
- Pharma index lagged broader Nifty 50 over the past year.
The Nifty Pharma index concluded today's trading session with a notable gain of 1.69%, reaching 23126.85. This performance was driven by strong individual stock movements, with Divis Laboratories Ltd adding 4.38%, Ipca Laboratories Ltd rising 4.01%, and Lupin Ltd gaining 3.17%. These advances contributed to a 1.00% increase for the index over the past month.
In contrast to the pharmaceutical sector's positive trend, broader market indices experienced declines. The Nifty 50 closed down 0.27% at 26178.7, while the SENSEX saw a steeper drop of 0.44% to 85063.34. Other sectoral indices also faltered, with the Nifty Infrastructure index down 1.18% and the Nifty Media index losing 1.05%.
Over the past year, the Nifty Pharma index's performance has lagged behind the benchmark Nifty 50. While the pharma index has seen a 0.00% change, the Nifty 50 has appreciated by 10.85%. This suggests a divergence in performance trends between the two indices over a longer timeframe.
